Stock Ownership/NGEN

NERVGEN PHARMA C (NGEN): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in NGEN. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
3
13F filers
Aggregate Value
$1.5M
Across holders
Last Price
$1.75
2026-10-08
Sector
GICS
Quarterly fund activity3 increased0 reduced0 exited
Institutional Holders of NGEN
↗
3 holders
Manager⇅Type⇅Shares⇅Market Value▼% of Total⇅% of Portfolio⇅Action⇅QoQ Change⇅Quarter⇅
MARSHALL WACE, LLP
CIK 0001318757
Hedge Fund436K$898K60.0%0.0%Added+$219KQ2 2026
Woodline Partners LP
CIK 0001784547
Hedge Fund251K$516K34.5%0.0%Added—Q2 2026
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
Hedge Fund40K$82K5.5%0.0%Added—Q2 2026
MARSHALL WACE, LLPAdded
Hedge Fund
$898K· 60.0% of total· 0.0% port· 436K sh· +$219K QoQ· Q2 2026
Woodline Partners LPAdded
Hedge Fund
$516K· 34.5% of total· 0.0% port· 251K sh· — QoQ· Q2 2026
MILLENNIUM MANAGEMENT LLCAdded
Hedge Fund
$82K· 5.5% of total· 0.0% port· 40K sh· — QoQ· Q2 2026
Loading recent insider activity…
← Stock ownership